81 related articles for article (PubMed ID: 30851247)
1. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma.
Su YF; Tsai EM; Chen CC; Wu CC; Er TK
Clin Chim Acta; 2019 Jul; 494():1-7. PubMed ID: 30851247
[TBL] [Abstract][Full Text] [Related]
2. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.
Jones S; Wang TL; Shih IeM; Mao TL; Nakayama K; Roden R; Glas R; Slamon D; Diaz LA; Vogelstein B; Kinzler KW; Velculescu VE; Papadopoulos N
Science; 2010 Oct; 330(6001):228-31. PubMed ID: 20826764
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of molecular profiles and molecular signatures in clear cell ovarian cancer.
Schnack TH; Oliveira DNP; Christiansen AP; Høgdall C; Høgdall E
Cancer Genet; 2023 Nov; 278-279():9-16. PubMed ID: 37567101
[TBL] [Abstract][Full Text] [Related]
4. DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
Cunningham JM; Winham SJ; Wang C; Weiglt B; Fu Z; Armasu SM; McCauley BM; Brand AH; Chiew YE; Elishaev E; Gourley C; Kennedy CJ; Laslavic A; Lester J; Piskorz A; Sekowska M; Brenton JD; Churchman M; DeFazio A; Drapkin R; Elias KM; Huntsman DG; Karlan BY; Köbel M; Konner J; Lawrenson K; Papaemmanuil E; Bolton KL; Modugno F; Goode EL
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):132-141. PubMed ID: 34697060
[TBL] [Abstract][Full Text] [Related]
5. A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE; Miller A; Soslow RA; Lankes HA; DeLair D; Segura S; Chavan S; Zamarin D; DeBernardo R; Moore K; Moroney J; Shahin M; Thaker PH; Wahner-Hendrickson AE; Aghajanian C
Gynecol Oncol; 2023 Sep; 176():16-24. PubMed ID: 37418832
[TBL] [Abstract][Full Text] [Related]
6. Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer.
Anabel Sinberger L; Zahavi T; Sonnenblick A; Salmon-Divon M
Sci Rep; 2023 Nov; 13(1):20911. PubMed ID: 38017109
[TBL] [Abstract][Full Text] [Related]
7. Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.
Bolton KL; Chen D; Corona de la Fuente R; Fu Z; Murali R; Köbel M; Tazi Y; Cunningham JM; Chan ICC; Wiley BJ; Moukarzel LA; Winham SJ; Armasu SM; Lester J; Elishaev E; Laslavic A; Kennedy CJ; Piskorz A; Sekowska M; Brand AH; Chiew YE; Pharoah P; Elias KM; Drapkin R; Churchman M; Gourley C; DeFazio A; Karlan B; Brenton JD; Weigelt B; Anglesio MS; Huntsman D; Gayther S; Konner J; Modugno F; Lawrenson K; Goode EL; Papaemmanuil E
Clin Cancer Res; 2022 Nov; 28(22):4947-4956. PubMed ID: 35816189
[TBL] [Abstract][Full Text] [Related]
8. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
[TBL] [Abstract][Full Text] [Related]
9. Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.
Kim YN; Chung YS; Lee JH; Park E; Lee ST; Kim S; Lee JY
J Gynecol Oncol; 2023 Nov; 34(6):e70. PubMed ID: 37417298
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.
Maeda D; Shih IeM
Adv Anat Pathol; 2013 Jan; 20(1):45-52. PubMed ID: 23232571
[TBL] [Abstract][Full Text] [Related]
11. Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.
Oda K; Hamanishi J; Matsuo K; Hasegawa K
Gynecol Oncol; 2018 Nov; 151(2):381-389. PubMed ID: 30217369
[TBL] [Abstract][Full Text] [Related]
12. Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations.
Song B; Lee SH; Park JH; Moon KC
Cancer Res Treat; 2024 Jan; 56(1):280-293. PubMed ID: 37697729
[TBL] [Abstract][Full Text] [Related]
13. ARID1A loss activates MAPK signaling via DUSP4 downregulation.
Mandal J; Yu ZC; Shih IM; Wang TL
J Biomed Sci; 2023 Dec; 30(1):94. PubMed ID: 38071325
[TBL] [Abstract][Full Text] [Related]
14. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
Foster KI; Shaw KRM; Jin J; Westin SN; Yap TA; Glassman DM; Jazaeri AA; Rauh-Hain JA; Lee S; Fellman BM; Ju Z; Liu Y; Fleming ND; Sood AK
Cancer; 2023 Jun; 129(11):1672-1680. PubMed ID: 36930815
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Somatic Mutation Profiles Between Formalin-Fixed Paraffin Embedded Tissues and Plasma Cell-Free DNA from Ovarian Cancer Patients Before and After Surgery.
Jagelkova M; Zelinova K; Laucekova Z; Bobrovska M; Dankova Z; Grendar M; Dokus K
Biores Open Access; 2020; 9(1):73-79. PubMed ID: 32219013
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers.
Wang M; Fan W; Ye M; Tian C; Zhao L; Wang J; Han W; Yang W; Gu C; Li M; Zhang Z; Wang Y; Zhang H; Meng Y
Sci Rep; 2018 Jun; 8(1):8990. PubMed ID: 29895933
[TBL] [Abstract][Full Text] [Related]
18. Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma.
Xiao M; Cui X; Xu C; Xin L; Zhao J; Yang S; Hong B; Tan Y; Zhang J; Li X; Li J; Kang C; Fang C
CNS Neurosci Ther; 2024 Apr; 30(4):e14698. PubMed ID: 38600891
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of ARID1A mutations with mRNA levels and protein expression in gastric carcinoma.
Hwang I; Cho Y; Kang SY; Kim DG; Ahn S; Lee J; Kim KM
Pathol Res Pract; 2024 Mar; 255():155063. PubMed ID: 38324965
[TBL] [Abstract][Full Text] [Related]
20. Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis.
Driva TS; Schatz C; Haybaeck J
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
